John Overdeck’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.02M | Buy |
669,808
+114,916
| +21% | +$954K | 0.01% | 1694 |
|
|
2026
Q1 | $4.65M | Buy |
554,892
+424,951
| +327% | +$4.46M | ﹤0.01% | 2042 |
|
|
2025
Q4 | $1.87M | Sell |
129,941
-24,345
| -16% | -$303K | ﹤0.01% | 2481 |
|
|
2025
Q3 | $1.49M | Sell |
154,286
-53,665
| -26% | -$475K | ﹤0.01% | 2327 |
|
|
2025
Q2 | $1.71M | Sell |
207,951
-118,757
| -36% | -$994K | ﹤0.01% | 1938 |
|
|
2025
Q1 | $2.34M | Sell |
326,708
-62,720
| -16% | -$467K | 0.01% | 1637 |
|
|
2024
Q4 | $3.01M | Buy |
389,428
+263,495
| +209% | +$2.47M | 0.01% | 1434 |
|
|
2024
Q3 | $1.32M | Sell |
125,933
-53,807
| -30% | -$656K | ﹤0.01% | 1949 |
|
|
2024
Q2 | $2.1M | Buy |
179,740
+89,756
| +100% | +$1.4M | ﹤0.01% | 1516 |
|
|
2024
Q1 | $1.9M | Sell |
89,984
-25,087
| -22% | -$446K | ﹤0.01% | 1523 |
|
|
2023
Q4 | $2.07M | Buy |
115,071
+84,859
| +281% | +$1.49M | ﹤0.01% | 1513 |
|
|
2023
Q3 | $497K | Buy |
+30,212
| New | +$547K | ﹤0.01% | 2280 |
|
|
2022
Q4 | – | Sell |
-39,362
| Closed | -$1.04M | – | 3033 |
|
|
2022
Q3 | $1.04M | Buy |
+39,362
| New | +$1.17M | ﹤0.01% | 1449 |
|
|
2022
Q2 | – | Sell |
-11,600
| Closed | -$385K | – | 2867 |
|
|
2022
Q1 | $385K | Buy |
+11,600
| New | +$322K | ﹤0.01% | 2130 |
|
|
2021
Q4 | – | Sell |
-150,994
| Closed | -$6.33M | – | 4779 |
|
|
2021
Q3 | $6.33M | Buy |
150,994
+132,394
| +712% | +$4.76M | 0.01% | 1055 |
|
|
2021
Q2 | $723K | Sell |
18,600
-100,006
| -84% | -$3.58M | ﹤0.01% | 2778 |
|
|
2021
Q1 | $4.05M | Buy |
118,606
+110,506
| +1,364% | +$4.71M | 0.01% | 1190 |
|
|
2020
Q4 | $367K | Sell |
8,100
-840
| -9% | -$29.4K | ﹤0.01% | 2723 |
|
|
2020
Q3 | $246K | Sell |
8,940
-34,751
| -80% | -$1.13M | ﹤0.01% | 2694 |
|
|
2020
Q2 | $1.61M | Buy |
+43,691
| New | +$1.63M | 0.01% | 1214 |
|
|
2019
Q2 | – | Sell |
-31,473
| Closed | -$1.8M | – | 3609 |
|
|
2019
Q1 | $1.8M | Sell |
31,473
-89,947
| -74% | -$4.46M | 0.01% | 1483 |
|
|
2018
Q4 | $5.09M | Sell |
121,420
-7,094
| -6% | -$416K | 0.02% | 789 |
|
|
2018
Q3 | $9.7M | Buy |
+128,514
| New | +$9.26M | 0.03% | 650 |
|
|
2018
Q2 | – | Sell |
-61,637
| Closed | -$1.84M | – | 3588 |
|
|
2018
Q1 | $1.84M | Sell |
61,637
-66,330
| -52% | -$1.93M | 0.01% | 1582 |
|
|
2017
Q4 | $4.25M | Buy |
127,967
+66,775
| +109% | +$2.01M | 0.01% | 980 |
|
|
2017
Q3 | $2.02M | Buy |
+61,192
| New | +$1.38M | 0.01% | 1305 |
|
Other funds holding RGNX
RG
John Overdeck's RGNX Position: Q2 2026 in Review
John Overdeck increased its Regenxbio (RGNX) stake by 21% in Q2 2026, buying an estimated $954K and bringing the position to 669,808 shares worth $8.02M. The position accounts for 0.01% of the portfolio, ranked #1694.
John Overdeck first reported a position in RGNX in Q3 2017 and has held it in 26 quarters since. The position peaked at $9.7M in Q3 2018. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- John Overdeck held 669,808 shares of Regenxbio worth $8.02M as of Q2 2026.
- John Overdeck bought 114,916 Regenxbio shares in Q2 2026, an estimated $954K.
- Regenxbio made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1694 holding.
- John Overdeck first reported a position in Regenxbio in Q3 2017 and has held it in 26 quarters since.
- John Overdeck's Regenxbio position peaked at $9.7M in Q3 2018.
- 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.